 LONDON, July 30, 2020 GLOBE NEWSWIRE -- Autolus Therapeutics plc Nasdaq: AUTL, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2020 financial results and operational highlights before open of U.S. markets on Thursday, August 6, 2020. Management will host a conference call and webcast at 8:30 am ET1:30 pm BST to discuss the companys financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to: access the live and subsequent replay of this webcast that will be live for two weeks and view the accompanying slide presentation, please register here.Contact: Lucinda Crabtree, PhD Vice President, Investor Relations and Corporate Communications 44 0 7587 372 619 Wilson 44 0 7818 430877 A. Noonan S.A. Noonan Communications 1-212-966-3650 